Les syndromes coronariens aigus: le present et le futur. [Acute coronary syndrome: present and future]
Details
Serval ID
serval:BIB_FC23CDF28850
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Les syndromes coronariens aigus: le present et le futur. [Acute coronary syndrome: present and future]
Journal
Revue Médicale de la Suisse Romande
ISSN
0035-3655 (Print)
Publication state
Published
Issued date
07/2004
Volume
124
Number
7
Pages
400-3
Notes
English Abstract
Journal Article
Review --- Old month value: Jul
Journal Article
Review --- Old month value: Jul
Abstract
The management of the acute coronary syndromes (ACS), made of the acute myocardial infarction (ACS with ST-segment elevation) and the unstable angina/non-Q wave myocardial infarction (ACS without ST-segment elevation), are a major source of research. BNP, myeloperaxidase or CD401 as biological markers of cardiac injuries and technological devices (intracoronary thermotools under investigations. On the therapeutic point of view, the early invasive strategy is confirmed. Therefore, the optimalization of the adjuvant treatment was broadly investigated. Ximelagatran, a new oral anticoagulant, should find a place in the management of our unstable patient based on recent studies. Finally, stem-cell transplantation after myocardial infarction will be probably a new treatment strategy. The first human study is just finished, demonstrating the benefit of this approach. The acute coronary syndromes are a major source of research based on the proof of today and on the wishes for tomorrow.
Keywords
Acute Disease
*Angina, Unstable/diagnosis/therapy
Forecasting
Humans
*Myocardial Infarction/diagnosis/therapy
Myocardial Ischemia/diagnosis
Syndrome
Pubmed
Create date
28/01/2008 9:51
Last modification date
20/08/2019 16:27